_version_ 1784720354999009280
author Mancini, Laura
Casagranda, Stefano
Gautier, Guillaume
Peter, Philippe
Lopez, Bruno
Thorne, Lewis
McEvoy, Andrew
Miserocchi, Anna
Samandouras, George
Kitchen, Neil
Brandner, Sebastian
De Vita, Enrico
Torrealdea, Francisco
Rega, Marilena
Schmitt, Benjamin
Liebig, Patrick
Sanverdi, Eser
Golay, Xavier
Bisdas, Sotirios
author_facet Mancini, Laura
Casagranda, Stefano
Gautier, Guillaume
Peter, Philippe
Lopez, Bruno
Thorne, Lewis
McEvoy, Andrew
Miserocchi, Anna
Samandouras, George
Kitchen, Neil
Brandner, Sebastian
De Vita, Enrico
Torrealdea, Francisco
Rega, Marilena
Schmitt, Benjamin
Liebig, Patrick
Sanverdi, Eser
Golay, Xavier
Bisdas, Sotirios
author_sort Mancini, Laura
collection PubMed
description
format Online
Article
Text
id pubmed-9165277
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91652772022-06-05 Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing Mancini, Laura Casagranda, Stefano Gautier, Guillaume Peter, Philippe Lopez, Bruno Thorne, Lewis McEvoy, Andrew Miserocchi, Anna Samandouras, George Kitchen, Neil Brandner, Sebastian De Vita, Enrico Torrealdea, Francisco Rega, Marilena Schmitt, Benjamin Liebig, Patrick Sanverdi, Eser Golay, Xavier Bisdas, Sotirios Eur J Nucl Med Mol Imaging Correction Springer Berlin Heidelberg 2022-04-12 2022 /pmc/articles/PMC9165277/ /pubmed/35412055 http://dx.doi.org/10.1007/s00259-022-05798-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Mancini, Laura
Casagranda, Stefano
Gautier, Guillaume
Peter, Philippe
Lopez, Bruno
Thorne, Lewis
McEvoy, Andrew
Miserocchi, Anna
Samandouras, George
Kitchen, Neil
Brandner, Sebastian
De Vita, Enrico
Torrealdea, Francisco
Rega, Marilena
Schmitt, Benjamin
Liebig, Patrick
Sanverdi, Eser
Golay, Xavier
Bisdas, Sotirios
Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing
title Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing
title_full Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing
title_fullStr Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing
title_full_unstemmed Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing
title_short Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing
title_sort correction to: cest mri provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165277/
https://www.ncbi.nlm.nih.gov/pubmed/35412055
http://dx.doi.org/10.1007/s00259-022-05798-6
work_keys_str_mv AT mancinilaura correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT casagrandastefano correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT gautierguillaume correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT peterphilippe correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT lopezbruno correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT thornelewis correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT mcevoyandrew correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT miserocchianna correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT samandourasgeorge correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT kitchenneil correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT brandnersebastian correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT devitaenrico correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT torrealdeafrancisco correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT regamarilena correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT schmittbenjamin correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT liebigpatrick correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT sanverdieser correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT golayxavier correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping
AT bisdassotirios correctiontocestmriprovidesamideaminesurrogatebiomarkersfortreatmentnaivegliomasubtyping